tiprankstipranks
Biontech Se Sponsored Adr (BNTX)
NASDAQ:BNTX
US Market
BNTX
BioNTech SE
RESEARCH TOOLSreports
Want to see BNTX full AI Analyst Report?

BioNTech SE (BNTX) Stock Forecast & Price Target

4,846 Followers
See the Price Targets and Ratings of:

BNTX Analyst Ratings

Strong Buy
16Ratings
Strong Buy
14 Buy
2 Hold
0 Sell
Based on 16 analysts giving stock ratings to
BioNTech
SE
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

BNTX Stock 12 Month Forecast

Average Price Target

$131.50
▲(27.77% Upside)
Based on 16 Wall Street analysts offering 12 month price targets for BioNTech SE in the last 3 months. The average price target is $131.50 with a high forecast of $167.00 and a low forecast of $89.55. The average price target represents a 27.77% change from the last price of $102.92.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"88":"$88","108":"$108","128":"$128","148":"$148","168":"$168"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":167,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$167.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":131.5038,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$131.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":89.55,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$89.55</span>\n  </div></div>","useHTML":true}}],"tickPositions":[88,108,128,148,168],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Nov<br/>2025","9":"Feb<br/>2026","12":"May<br/>2026","25":"May<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,97.54,102.88307692307693,108.22615384615385,113.56923076923077,118.91230769230769,124.25538461538461,129.59846153846155,134.94153846153847,140.2846153846154,145.6276923076923,150.97076923076924,156.31384615384616,161.65692307692308,{"y":167,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,97.54,100.1526,102.76520000000001,105.37780000000001,107.99040000000001,110.60300000000001,113.21560000000001,115.82820000000001,118.44080000000001,121.05340000000001,123.66600000000001,126.27860000000001,128.89120000000003,{"y":131.5038,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,97.54,96.92538461538462,96.31076923076924,95.69615384615385,95.08153846153847,94.46692307692308,93.85230769230769,93.23769230769231,92.62307692307692,92.00846153846153,91.39384615384616,90.77923076923076,90.16461538461539,{"y":89.55,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":102.43,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 58,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":113.1,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 58,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":107.51,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 48,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":107.34,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":100.62,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":102.21,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":103.91,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":97.39,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":95.2,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":108.88,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":107.48,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":89.42,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":97.54,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$167.00Average Price Target$131.50Lowest Price Target$89.55
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Canaccord Genuity Analyst forecast on BNTX
John Newman
Canaccord Genuity
Canaccord Genuity
$158
Buy
53.52%
Upside
Assigned
05/21/26
Analysts Conflicted on These Healthcare Names: InMode (NASDAQ: INMD), Achieve Life Sciences (NASDAQ: ACHV) and BioNTech SE (NASDAQ: BNTX)
J.P. Morgan Analyst forecast on BNTX
Unknown Analyst
J.P. Morgan
Not Ranked
J.P. Morgan
$100
Hold
-2.84%
Downside
Reiterated
05/20/26
J.P. Morgan Keeps Their Hold Rating on BioNTech SE (BNTX)
Morgan Stanley Analyst forecast on BNTX
Terence Flynn
Morgan Stanley
Morgan Stanley
$126→$89.55
Buy
-12.99%
Downside
Reiterated
05/18/26
Analysts' Top Healthcare Picks: Monopar Therapeutics Inc (MNPR), Voyager Therapeutics (VYGR)
BMO Capital Analyst forecast on BNTX
Evan Seigerman
BMO Capital
BMO Capital
$128
Buy
24.37%
Upside
Reiterated
05/11/26
Analysts Offer Insights on Healthcare Companies: Enliven Therapeutics (NASDAQ: ELVN), BioNTech SE (NASDAQ: BNTX) and Kodiak Sciences (NASDAQ: KOD)
Berenberg Bank Analyst forecast on BNTX
Harry Gillis
Berenberg Bank
Berenberg Bank
$155→$140
Buy
36.03%
Upside
Reiterated
05/11/26
Analysts Offer Insights on Healthcare Companies: Argenx Se (NASDAQ: ARGX), Siemens Healthineers AG (Other OTC: SEMHF) and BioNTech SE (NASDAQ: BNTX)
Wells Fargo Analyst forecast on BNTX
Mohit Bansal
Wells Fargo
Wells Fargo
$150→$140.01
Buy
36.03%
Upside
Reiterated
05/06/26
BioNTech SE (BNTX) Receives a Buy from Wells Fargo
TD Cowen Analyst forecast on BNTX
Yaron Werber
TD Cowen
TD Cowen
$94
Hold
-8.67%
Downside
Reiterated
05/05/26
Analysts Offer Insights on Healthcare Companies: Orthofix Medical (NASDAQ: OFIX), BioNTech SE (NASDAQ: BNTX) and Cogent Biosciences (NASDAQ: COGT)
Goldman Sachs Analyst forecast on BNTX
Asad Haider
Goldman Sachs
Goldman Sachs
$132→$133
Buy
29.23%
Upside
Reiterated
05/05/26
BioNTech SE (BNTX) Receives a Buy from Goldman Sachs
H.C. Wainwright Analyst forecast on BNTX
Robert Burns
H.C. Wainwright
H.C. Wainwright
$130
Buy
26.31%
Upside
Reiterated
04/27/26
Analyst Reiterates Buy on BioNTech, Maintains $130 Price Target on Strength of Pumitamig Oncology Pipeline
Bank of America Securities Analyst forecast on BNTX
Tazeen Ahmad
Bank of America Securities
Bank of America Securities
―
Buy
―
Reiterated
04/16/26
Analysts Offer Insights on Healthcare Companies: Eton Pharmaceuticals (NASDAQ: ETON), BioNTech SE (NASDAQ: BNTX) and CareDx (NASDAQ: CDNA)
Jefferies Analyst forecast on BNTX
Akash Tewari
Jefferies
Jefferies
$138
Buy
34.08%
Upside
Reiterated
03/25/26
Analysts Offer Insights on Healthcare Companies: BioNTech SE (NASDAQ: BNTX) and Biomea Fusion (NASDAQ: BMEA)
Deutsche Bank Analyst forecast on BNTX
Emmanuel Papadakis
Deutsche Bank
Deutsche Bank
$140
Buy
36.03%
Upside
Reiterated
03/17/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Truist Financial Analyst forecast on BNTX
Asthika Goonewardene
Truist Financial
Truist Financial
$155
Buy
50.60%
Upside
Reiterated
03/13/26
Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF), BioNTech SE (NASDAQ: BNTX) and Skye Bioscience (NASDAQ: SKYE)
Evercore ISI Analyst forecast on BNTX
Cory Kasimov
Evercore ISI
Evercore ISI
$130
Buy
26.31%
Upside
Reiterated
03/11/26
Evercore ISI Remains a Buy on BioNTech SE (BNTX)
Citi Analyst forecast on BNTX
Geoff Meacham
Citi
Citi
$145→$130
Buy
26.31%
Upside
Reiterated
03/11/26
BioNTech price target lowered to $130 from $145 at CitiBioNTech price target lowered to $130 from $145 at Citi
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Canaccord Genuity Analyst forecast on BNTX
John Newman
Canaccord Genuity
Canaccord Genuity
$158
Buy
53.52%
Upside
Assigned
05/21/26
Analysts Conflicted on These Healthcare Names: InMode (NASDAQ: INMD), Achieve Life Sciences (NASDAQ: ACHV) and BioNTech SE (NASDAQ: BNTX)
J.P. Morgan Analyst forecast on BNTX
Unknown Analyst
J.P. Morgan
Not Ranked
J.P. Morgan
$100
Hold
-2.84%
Downside
Reiterated
05/20/26
J.P. Morgan Keeps Their Hold Rating on BioNTech SE (BNTX)
Morgan Stanley Analyst forecast on BNTX
Terence Flynn
Morgan Stanley
Morgan Stanley
$126→$89.55
Buy
-12.99%
Downside
Reiterated
05/18/26
Analysts' Top Healthcare Picks: Monopar Therapeutics Inc (MNPR), Voyager Therapeutics (VYGR)
BMO Capital Analyst forecast on BNTX
Evan Seigerman
BMO Capital
BMO Capital
$128
Buy
24.37%
Upside
Reiterated
05/11/26
Analysts Offer Insights on Healthcare Companies: Enliven Therapeutics (NASDAQ: ELVN), BioNTech SE (NASDAQ: BNTX) and Kodiak Sciences (NASDAQ: KOD)
Berenberg Bank Analyst forecast on BNTX
Harry Gillis
Berenberg Bank
Berenberg Bank
$155→$140
Buy
36.03%
Upside
Reiterated
05/11/26
Analysts Offer Insights on Healthcare Companies: Argenx Se (NASDAQ: ARGX), Siemens Healthineers AG (Other OTC: SEMHF) and BioNTech SE (NASDAQ: BNTX)
Wells Fargo Analyst forecast on BNTX
Mohit Bansal
Wells Fargo
Wells Fargo
$150→$140.01
Buy
36.03%
Upside
Reiterated
05/06/26
BioNTech SE (BNTX) Receives a Buy from Wells Fargo
TD Cowen Analyst forecast on BNTX
Yaron Werber
TD Cowen
TD Cowen
$94
Hold
-8.67%
Downside
Reiterated
05/05/26
Analysts Offer Insights on Healthcare Companies: Orthofix Medical (NASDAQ: OFIX), BioNTech SE (NASDAQ: BNTX) and Cogent Biosciences (NASDAQ: COGT)
Goldman Sachs Analyst forecast on BNTX
Asad Haider
Goldman Sachs
Goldman Sachs
$132→$133
Buy
29.23%
Upside
Reiterated
05/05/26
BioNTech SE (BNTX) Receives a Buy from Goldman Sachs
H.C. Wainwright Analyst forecast on BNTX
Robert Burns
H.C. Wainwright
H.C. Wainwright
$130
Buy
26.31%
Upside
Reiterated
04/27/26
Analyst Reiterates Buy on BioNTech, Maintains $130 Price Target on Strength of Pumitamig Oncology Pipeline
Bank of America Securities Analyst forecast on BNTX
Tazeen Ahmad
Bank of America Securities
Bank of America Securities
―
Buy
―
Reiterated
04/16/26
Analysts Offer Insights on Healthcare Companies: Eton Pharmaceuticals (NASDAQ: ETON), BioNTech SE (NASDAQ: BNTX) and CareDx (NASDAQ: CDNA)
Jefferies Analyst forecast on BNTX
Akash Tewari
Jefferies
Jefferies
$138
Buy
34.08%
Upside
Reiterated
03/25/26
Analysts Offer Insights on Healthcare Companies: BioNTech SE (NASDAQ: BNTX) and Biomea Fusion (NASDAQ: BMEA)
Deutsche Bank Analyst forecast on BNTX
Emmanuel Papadakis
Deutsche Bank
Deutsche Bank
$140
Buy
36.03%
Upside
Reiterated
03/17/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Truist Financial Analyst forecast on BNTX
Asthika Goonewardene
Truist Financial
Truist Financial
$155
Buy
50.60%
Upside
Reiterated
03/13/26
Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF), BioNTech SE (NASDAQ: BNTX) and Skye Bioscience (NASDAQ: SKYE)
Evercore ISI Analyst forecast on BNTX
Cory Kasimov
Evercore ISI
Evercore ISI
$130
Buy
26.31%
Upside
Reiterated
03/11/26
Evercore ISI Remains a Buy on BioNTech SE (BNTX)
Citi Analyst forecast on BNTX
Geoff Meacham
Citi
Citi
$145→$130
Buy
26.31%
Upside
Reiterated
03/11/26
BioNTech price target lowered to $130 from $145 at CitiBioNTech price target lowered to $130 from $145 at Citi
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering BioNTech SE

3 Months
Robert BurnsH.C. Wainwright
Success Rate
11/25 ratings generated profit
44%
Average Return
+0.62%
Copying Robert Burns's trades and holding each position for 3 Months would result in 44.00% of your transactions generating a profit, with an average return of +0.62% per trade.
1 Year
Robert BurnsH.C. Wainwright
Success Rate
12/25 ratings generated profit
48%
Average Return
+0.47%
Copying Robert Burns's trades and holding each position for 1 Year would result in 48.00% of your transactions generating a profit, with an average return of +0.47% per trade.
2 Years
Robert BurnsH.C. Wainwright
Success Rate
10/25 ratings generated profit
40%
Average Return
-4.21%
Copying Robert Burns's trades and holding each position for 2 Years would result in 40.00% of your transactions generating a profit, with an average return of -4.21% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BNTX Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
7
4
7
9
12
Buy
31
20
20
16
18
Hold
2
1
2
3
4
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
40
25
29
28
34
In the current month, BNTX has received 30 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. BNTX average Analyst price target in the past 3 months is 131.50.
Each month's total comprises the sum of three months' worth of ratings.

BNTX Financial Forecast

BNTX Earnings Forecast

Next quarter’s earnings estimate for BNTX is -$2.43 with a range of -$3.58 to -$1.67. The previous quarter’s EPS was -$2.44. BNTX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year BNTX has Performed in-line its overall industry.
Next quarter’s earnings estimate for BNTX is -$2.43 with a range of -$3.58 to -$1.67. The previous quarter’s EPS was -$2.44. BNTX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year BNTX has Performed in-line its overall industry.

BNTX Sales Forecast

Next quarter’s sales forecast for BNTX is $208.88M with a range of $141.08M to $398.62M. The previous quarter’s sales results were $138.17M. BNTX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year BNTX has Performed in-line its overall industry.
Next quarter’s sales forecast for BNTX is $208.88M with a range of $141.08M to $398.62M. The previous quarter’s sales results were $138.17M. BNTX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year BNTX has Performed in-line its overall industry.

BNTX Stock Forecast FAQ

What is BNTX’s average 12-month price target, according to analysts?
Based on analyst ratings, Biontech Se Sponsored Adr’s 12-month average price target is 131.50.
    What is BNTX’s upside potential, based on the analysts’ average price target?
    Biontech Se Sponsored Adr has 27.77% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is BNTX a Buy, Sell or Hold?
          Biontech Se Sponsored Adr has a consensus rating of Strong Buy which is based on 14 buy ratings, 2 hold ratings and 0 sell ratings.
            What is Biontech Se Sponsored Adr’s price target?
            The average price target for Biontech Se Sponsored Adr is 131.50. This is based on 16 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $167.00 ,the lowest forecast is $89.55. The average price target represents 27.77% Increase from the current price of $102.92.
              What do analysts say about Biontech Se Sponsored Adr?
              Biontech Se Sponsored Adr’s analyst rating consensus is a Strong Buy. This is based on the ratings of 16 Wall Streets Analysts.
                How can I buy shares of BNTX?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.